L Norton Selected Research

L Norton Research Topics

Disease

33	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2000
27	Neoplasms (Cancer) 11/2018 - 01/2000
7	Neoplasm Metastasis (Metastasis) 08/2015 - 02/2000
5	Type 2 Diabetes Mellitus (MODY) 05/2016 - 03/2007
5	Leukemia 12/2005 - 03/2000
4	Insulin Resistance 03/2008 - 01/2007
2	Carcinoma (Carcinomatosis) 06/2014 - 04/2001
2	Fatigue 12/2011 - 04/2001
2	Diarrhea 12/2011 - 04/2001
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2007 - 02/2007
2	Cardiotoxicity 12/2005 - 01/2000
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2005 - 04/2001
2	Osteoporosis 12/2001 - 01/2001
2	Disease Progression 03/2001 - 02/2000
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2016
1	Myocardial Infarction 05/2016
1	Stroke (Strokes) 05/2016
1	Lobular Carcinoma 01/2014
1	Pancreatitis 03/2013
1	Inflammation (Inflammations) 09/2012
1	Wounds and Injuries (Trauma) 09/2012
1	Infections 09/2012
1	Exanthema (Rash) 12/2011
1	Coma (Comas) 11/2008
1	Heart Arrest (Cardiac Arrest) 11/2008
1	Overweight 07/2007
1	Starvation 03/2007
1	Necrosis 01/2006
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2005
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2004
1	Lymphoma (Lymphomas) 10/2004

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2010 - 01/2000
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 01/2000
7	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2009 - 01/2000
6	Trastuzumab (Herceptin)FDA Link 01/2016 - 01/2000
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2009 - 01/2000
4	Estrogen ReceptorsIBA 01/2014 - 10/2000
4	Selective Estrogen Receptor Modulators (SERM)IBA 09/2008 - 01/2001
3	Fluorouracil (Carac)FDA LinkGeneric 02/2009 - 10/2000
3	Raloxifene Hydrochloride (Evista)FDA Link 09/2008 - 01/2001
3	Insulin (Novolin)FDA Link 09/2007 - 02/2007
3	AntibodiesIBA 01/2006 - 03/2001
3	Monoclonal AntibodiesIBA 03/2001 - 01/2000
2	Circulating Tumor DNAIBA 11/2018 - 01/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2016 - 02/2000
2	N,N'-bis(4-azidobenzoyl)cystineIBA 10/2014 - 10/2014
2	Cadherins (E-Cadherin)IBA 06/2014 - 02/2000
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 11/2000
2	Methotrexate (Mexate)FDA LinkGeneric 02/2009 - 04/2001
2	Messenger RNA (mRNA)IBA 03/2008 - 07/2007
2	Blood Glucose (Blood Sugar)IBA 09/2007 - 02/2007
2	CarbohydratesIBA 03/2007 - 03/2001
2	Glucose (Dextrose)FDA LinkGeneric 02/2007 - 01/2007
2	GlycogenIBA 02/2007 - 01/2007
2	AnthracyclinesIBA 12/2005 - 04/2001
2	Tamoxifen FDA LinkGeneric 12/2001 - 10/2000
2	Immunoglobulin M (IgM)IBA 03/2001 - 05/2000
2	Immunoglobulin G (IgG)IBA 03/2001 - 05/2000
1	Pioglitazone (Actos)FDA Link 05/2016
1	empagliflozinIBA 05/2016
1	omega-Chloroacetophenone (Mace)IBA 05/2016
1	pertuzumabIBA 01/2016
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 06/2014
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2014
1	Isoniazid (Ftivazide)FDA LinkGeneric 03/2013
1	Dasatinib (BMS 354825)FDA Link 12/2011
1	Transcription Factors (Transcription Factor)IBA 12/2011
1	Taxoids (Taxanes)IBA 12/2011
1	Capecitabine (Xeloda)FDA Link 11/2010
1	Hormones (Hormone)IBA 09/2008
1	exemestane (Aromasin)FDA Link 09/2008
1	Aromatase InhibitorsIBA 09/2008
1	Letrozole (Femara)FDA LinkGeneric 05/2008
1	LipidsIBA 03/2008
1	Liver GlycogenIBA 09/2007
1	Fatty Acid-Binding ProteinsIBA 07/2007
1	Fatty Acid Transport Proteins (Fatty Acid Transport Protein)IBA 07/2007
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2007
1	LigandsIBA 01/2006
1	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2005
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 05/2005
1	Prednisone (Sone)FDA LinkGeneric 10/2004
1	Vincristine (Oncovin)FDA LinkGeneric 10/2004
1	Leucovorin (Folinic Acid)FDA Link 05/2003
1	Anticarcinogenic AgentsIBA 12/2001
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2001
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2001
1	Macrocyclic LactamsIBA 08/2001
1	tanespimycin (17AAG)IBA 08/2001

Therapy/Procedure

11	Therapeutics 08/2015 - 01/2000
10	Drug Therapy (Chemotherapy) 12/2005 - 01/2000
5	Adjuvant Chemotherapy 12/2001 - 03/2000
1	Debridement 09/2012
1	Radiotherapy 02/2009
1	Mastectomy (Mammectomy) 02/2009
1	Resuscitation 11/2008
1	Induced Hypothermia 11/2008
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2005
1	CAV protocol 10/2004